| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.12e-06 | 152 | 138 | 9 | GO:0016779 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH9 MYH11 EP400 ZGRF1 YTHDC2 ACSF2 SMC2 KIF3B KIF15 DNAH17 MOV10L1 AFG3L2 AACS MACF1 ATP11C ASCC3 YME1L1 | 1.20e-06 | 614 | 138 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | TUT4 EP400 POLA1 ZGRF1 POLR2B APTX POLR1C DARS1 YTHDC2 TARS3 IARS2 MOV10L1 ASCC3 REV1 | 1.55e-04 | 645 | 138 | 14 | GO:0140640 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PRUNE2 APTX YTHDC2 GIMAP7 SMC2 ITPA EEF1A2 KIF3B KIF15 MOV10L1 AFG3L2 MACF1 ATP11C ASCC3 SEPTIN7 YME1L1 | 2.28e-04 | 839 | 138 | 16 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PRUNE2 APTX YTHDC2 GIMAP7 SMC2 ITPA EEF1A2 KIF3B KIF15 MOV10L1 AFG3L2 MACF1 ATP11C ASCC3 SEPTIN7 YME1L1 | 2.31e-04 | 840 | 138 | 16 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PRUNE2 APTX YTHDC2 GIMAP7 SMC2 ITPA EEF1A2 KIF3B KIF15 MOV10L1 AFG3L2 MACF1 ATP11C ASCC3 SEPTIN7 YME1L1 | 2.31e-04 | 840 | 138 | 16 | GO:0016818 |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 3.40e-04 | 134 | 138 | 6 | GO:0003697 | |
| Domain | FXR_C1 | 5.19e-05 | 2 | 135 | 2 | IPR032172 | |
| Domain | FXR_C1 | 5.19e-05 | 2 | 135 | 2 | PF16096 | |
| Domain | P-loop_NTPase | MYH9 MYH11 EP400 ZGRF1 YTHDC2 GIMAP7 SMC2 EEF1A2 KIF3B KIF15 MOV10L1 AFG3L2 ASCC3 SEPTIN7 YME1L1 GNL3 MPP7 | 1.33e-04 | 848 | 135 | 17 | IPR027417 |
| Domain | Agenet | 1.55e-04 | 3 | 135 | 2 | PF05641 | |
| Domain | AGENET_LIKE | 1.55e-04 | 3 | 135 | 2 | PS51641 | |
| Domain | FXMRP1_C_core | 1.55e-04 | 3 | 135 | 2 | IPR022034 | |
| Domain | FtsH | 1.55e-04 | 3 | 135 | 2 | IPR005936 | |
| Domain | Agenet-like_dom | 1.55e-04 | 3 | 135 | 2 | IPR008395 | |
| Domain | Peptidase_M41 | 1.55e-04 | 3 | 135 | 2 | IPR000642 | |
| Domain | Peptidase_M41 | 1.55e-04 | 3 | 135 | 2 | PF01434 | |
| Domain | ITPase-like_fam | 1.55e-04 | 3 | 135 | 2 | IPR029001 | |
| Domain | FXMRP1_C_core | 1.55e-04 | 3 | 135 | 2 | PF12235 | |
| Domain | - | 1.55e-04 | 3 | 135 | 2 | 3.90.950.10 | |
| Domain | NA-bd_OB-fold | 3.39e-04 | 83 | 135 | 5 | IPR012340 | |
| Domain | BRCT_2 | 5.11e-04 | 5 | 135 | 2 | PF16589 | |
| Domain | Mab-21-like_1/2 | 5.11e-04 | 5 | 135 | 2 | IPR020950 | |
| Domain | - | 7.63e-04 | 6 | 135 | 2 | 3.90.1290.10 | |
| Domain | Plectin | 1.06e-03 | 7 | 135 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.06e-03 | 7 | 135 | 2 | IPR001101 | |
| Domain | PLEC | 1.06e-03 | 7 | 135 | 2 | SM00250 | |
| Domain | S1 | 1.41e-03 | 8 | 135 | 2 | PF00575 | |
| Domain | zf-C2H2_11 | 1.81e-03 | 9 | 135 | 2 | PF16622 | |
| Domain | Rap_GAP | 2.25e-03 | 10 | 135 | 2 | PF02145 | |
| Domain | Rap_GAP_dom | 2.73e-03 | 11 | 135 | 2 | IPR000331 | |
| Domain | RAPGAP | 2.73e-03 | 11 | 135 | 2 | PS50085 | |
| Domain | - | EP400 ZGRF1 YTHDC2 GIMAP7 SMC2 EEF1A2 MOV10L1 AFG3L2 ASCC3 SEPTIN7 YME1L1 GNL3 MPP7 | 2.95e-03 | 746 | 135 | 13 | 3.40.50.300 |
| Domain | S1 | 3.26e-03 | 12 | 135 | 2 | SM00316 | |
| Domain | tRNA_anti-codon | 3.26e-03 | 12 | 135 | 2 | PF01336 | |
| Domain | S1_dom | 3.26e-03 | 12 | 135 | 2 | IPR022967 | |
| Domain | NA-bd_OB_tRNA | 3.26e-03 | 12 | 135 | 2 | IPR004365 | |
| Domain | S1_domain | 3.26e-03 | 12 | 135 | 2 | IPR003029 | |
| Domain | Mab-21 | 3.26e-03 | 12 | 135 | 2 | PF03281 | |
| Domain | Mab-21 | 3.26e-03 | 12 | 135 | 2 | SM01265 | |
| Domain | Mab-21_dom | 3.26e-03 | 12 | 135 | 2 | IPR024810 | |
| Domain | Aldolase_TIM | 3.94e-03 | 44 | 135 | 3 | IPR013785 | |
| Domain | - | 5.12e-03 | 15 | 135 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 5.12e-03 | 15 | 135 | 2 | SM00501 | |
| Domain | ARID_dom | 5.12e-03 | 15 | 135 | 2 | IPR001606 | |
| Domain | ARID | 5.12e-03 | 15 | 135 | 2 | PS51011 | |
| Domain | Myosin_N | 5.12e-03 | 15 | 135 | 2 | PF02736 | |
| Domain | ARID | 5.12e-03 | 15 | 135 | 2 | PF01388 | |
| Domain | Myosin_N | 5.12e-03 | 15 | 135 | 2 | IPR004009 | |
| Pubmed | MYH9 ANK2 IQGAP2 FXR2 SMC2 GDI2 LETM1 EEF1A2 FXR1 KIF3B AKAP9 KIF15 ZKSCAN1 P2RX7 UBR5 CTCF SIPA1L1 MACF1 TLN2 QSER1 CDC5L RAPGEF2 SEPTIN7 LRRFIP1 | 8.06e-13 | 963 | 139 | 24 | 28671696 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYH9 REXO4 FXR2 POLR2B POLR1C EVPL DARS1 YTHDC2 SMC2 ITPR2 IARS2 TRMT6 FXR1 PSIP1 UTP11 SIPA1L1 NUP210 AFG3L2 PDCD11 CRYBG1 CDC5L ASCC3 SEPTIN7 RPL3 GNL3 LRRFIP1 TPI1 | 8.17e-13 | 1257 | 139 | 27 | 36526897 |
| Pubmed | MYH9 MYH11 ANK2 SYN3 IQGAP2 DOCK8 ADGRL1 DARS1 YTHDC2 GABARAPL2 GDI2 LETM1 EEF1A2 ITPR2 TARS3 FXR1 FGD4 SIPA1L1 AFG3L2 MACF1 TLN2 CDC5L RAPGEF2 SEPTIN7 RPL3 CAP1 LRRFIP1 TPI1 | 2.68e-12 | 1431 | 139 | 28 | 37142655 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | MYH9 FXR2 POLR1C YTHDC2 SMC2 STN1 EEF1A2 UBC TRMT6 FXR1 AFG3L2 PDCD11 CDC5L ASCC3 RPL3 YME1L1 GNL3 | 1.28e-11 | 486 | 139 | 17 | 30940648 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH9 REXO4 ATR POLA1 POLR2B DARS1 YTHDC2 SMC2 GDI2 LETM1 IARS2 TRMT6 FXR1 PSIP1 GGCT NUP210 PDCD11 TLN2 BOD1L1 EEA1 CDC5L SEPTIN7 RPL3 GNL3 CAP1 TPI1 | 8.35e-11 | 1425 | 139 | 26 | 30948266 |
| Pubmed | MYH9 ATR EP400 POLA1 KDM5C POLR2B POLR2G POLR1C SMC2 GDI2 UBC POLR3D PSIP1 UBR5 CTCF NANS LTA4H BOD1L1 QSER1 CDC5L GNL3 TPI1 | 1.14e-10 | 1014 | 139 | 22 | 32416067 | |
| Pubmed | MYH9 REXO4 FXR2 POLA1 YTHDC2 GDI2 IARS2 FXR1 UBR5 CTCF NUP210 PDCD11 MACF1 LTA4H ASCC3 RPL3 GNL3 CAP1 | 1.50e-10 | 653 | 139 | 18 | 22586326 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH9 REXO4 EP400 EML4 POLA1 POLR2B POLR1C DARS1 SMC2 RAB3GAP1 EIF2D FXR1 UBR5 GGCT NANS AFG3L2 PDCD11 MACF1 CDC5L ASCC3 RPL3 YME1L1 GNL3 CAP1 TPI1 | 1.56e-10 | 1353 | 139 | 25 | 29467282 |
| Pubmed | MYH9 REXO4 MYH11 ANK2 EP400 IQGAP2 FXR2 EML4 APTX DARS1 ITPA EEF1A2 TRMT6 FXR1 AKAP9 PSIP1 CTCF PDCD11 COL14A1 EEA1 ASCC3 CRBN GNL3 LRRFIP1 TPI1 | 2.06e-10 | 1371 | 139 | 25 | 36244648 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH9 FXR2 EML4 POLA1 POLR2B BAG5 POLR2G POLR1C DARS1 SMC2 LETM1 FXR1 PSIP1 UBR5 GGCT AFG3L2 PRKAG1 MACF1 LSM2 CDC5L RPL3 GNL3 PLIN3 LRRFIP1 TPI1 | 3.95e-10 | 1415 | 139 | 25 | 28515276 |
| Pubmed | MYH9 MYH11 FXR2 EVPL GDI2 UBC FXR1 GGCT MACF1 EEA1 RPL3 CAP1 TPI1 | 7.97e-10 | 327 | 139 | 13 | 31409639 | |
| Pubmed | ANK2 POLR2B BAG5 POLR1C CPD LETM1 EEF1A2 ITPR2 RAB3GAP1 IARS2 AKAP9 PSIP1 UBR5 NUP210 AFG3L2 PDCD11 MACF1 COL14A1 CDC5L ASCC3 RPL3 YME1L1 GNL3 MPP7 TPI1 | 1.09e-09 | 1487 | 139 | 25 | 33957083 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYH9 IQGAP2 FXR2 POLR2B BAG5 DARS1 SMC2 GDI2 EEF1A2 FXR1 UBR5 MACF1 LTA4H EEA1 CDC5L ASCC3 SEPTIN7 RPL3 GNL3 PLIN3 CAP1 TPI1 | 1.17e-09 | 1149 | 139 | 22 | 35446349 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | REXO4 IQGAP2 FXR2 POLR2B POLR1C DARS1 YTHDC2 SMC2 UBC FXR1 PSIP1 PDCD11 MACF1 CDC5L ASCC3 YME1L1 GNL3 LRRFIP1 | 1.63e-09 | 759 | 139 | 18 | 35915203 |
| Pubmed | IQGAP2 FXR2 POLR2B BAG5 POLR1C YTHDC2 MAB21L2 SMC2 PTGFRN LETM1 ITPR2 RAB3GAP1 IARS2 PSIP1 UBR5 CEP44 SIPA1L1 NUP210 AFG3L2 PDCD11 CDC5L ASCC3 PLIN3 LRRFIP1 | 2.92e-09 | 1440 | 139 | 24 | 30833792 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | MYH9 REXO4 TUT4 FXR2 POLR2B YTHDC2 GDI2 UBC FXR1 PSIP1 UTP11 PDCD11 MACF1 LSM2 CDC5L ASCC3 RPL3 GNL3 | 4.24e-09 | 807 | 139 | 18 | 22681889 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH9 MYH11 DARS1 GDI2 EEF1A2 IARS2 UBC AKAP9 PSIP1 GGCT NANS MOV10L1 MACF1 LTA4H EEA1 RPL3 CAP1 TPI1 | 4.24e-09 | 807 | 139 | 18 | 30575818 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EP400 POLR2B DARS1 YTHDC2 SMC2 ITPR2 UBC FXR1 PSIP1 UBR5 NUP210 AFG3L2 PDCD11 MACF1 EEA1 CDC5L ASCC3 RPL3 GNL3 TPI1 | 5.17e-09 | 1024 | 139 | 20 | 24711643 |
| Pubmed | MYH9 FXR2 POLR2B BAG5 POLR1C DARS1 SMC2 GDI2 EIF2D FXR1 AKAP9 CTCF SIPA1L1 AFG3L2 RASSF8 CDC5L ASCC3 SEPTIN7 RPL3 GNL3 PLIN3 CAP1 | 5.22e-09 | 1247 | 139 | 22 | 27684187 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MYH9 ANK2 EP400 DARS1 YTHDC2 EEF1A2 IARS2 PSIP1 CTCF CEP44 AFG3L2 MACF1 LTA4H BOD1L1 CDC5L RPL3 GNL3 PLIN3 TPI1 | 6.76e-09 | 934 | 139 | 19 | 33916271 |
| Pubmed | POLR2B POLR1C DARS1 YTHDC2 SMC2 POLR3D TRMT6 FXR1 LSM2 CDC5L SEPTIN7 RPL3 LRRFIP1 TPI1 | 6.85e-09 | 469 | 139 | 14 | 37314180 | |
| Pubmed | PRUNE2 MYH11 ZNF407 RALGAPA2 NPHP4 PTGFRN ZKSCAN5 RAB3GAP1 EEPD1 DNAH17 NUP210 MACF1 CEP152 CDC5L | 1.28e-08 | 493 | 139 | 14 | 15368895 | |
| Pubmed | MYH9 POLR2B POLR1C DARS1 UBC FXR1 CTCF AFG3L2 PRKAG1 MACF1 EEA1 ASCC3 RPL3 YME1L1 GNL3 | 2.09e-08 | 601 | 139 | 15 | 33658012 | |
| Pubmed | MYH9 ANK2 DARS1 YTHDC2 CPD SMC2 LETM1 AFG3L2 MACF1 BOD1L1 ASCC3 SEPTIN7 RPL3 PLIN3 CAP1 MPP7 | 2.74e-08 | 708 | 139 | 16 | 39231216 | |
| Pubmed | MYH9 POLA1 POLR2B BAG5 DARS1 SMC2 ITPA EEF1A2 UBR5 MACF1 SEPTIN7 RPL3 CAP1 TPI1 | 3.80e-08 | 538 | 139 | 14 | 28524877 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 4.08e-08 | 235 | 139 | 10 | 30258100 | |
| Pubmed | EML4 POLA1 POLR2B BAG5 DARS1 SMC2 FXR1 NUP210 PDCD11 CDC5L ASCC3 SEPTIN7 RPL3 GNL3 CAP1 | 4.58e-08 | 638 | 139 | 15 | 33239621 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRUNE2 MYH9 POLA1 POLR2B BAG5 POLR1C DARS1 SMC2 GDI2 EEF1A2 RAB3GAP1 TRMT6 KIF15 NANS MACF1 LSM2 SEPTIN7 RPL3 PRRC1 PLIN3 CAP1 LRRFIP1 | 8.02e-08 | 1455 | 139 | 22 | 22863883 |
| Pubmed | REXO4 FXR2 POLR2B YTHDC2 FXR1 CTCF UTP11 PDCD11 ASCC3 GNL3 LRRFIP1 | 1.07e-07 | 332 | 139 | 11 | 25693804 | |
| Pubmed | TUT4 EP400 FXR2 KDM5C POLR2B YTHDC2 RALGAPA2 ZKSCAN5 SOWAHA FXR1 UBR5 CTCF SIPA1L1 AFG3L2 MACF1 ASCC3 RAPGEF2 YME1L1 GNL3 | 1.12e-07 | 1116 | 139 | 19 | 31753913 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | MYH9 IQGAP2 SMC2 EEF1A2 FXR1 PSIP1 NANS MACF1 TLN2 BOD1L1 SEPTIN7 PLIN3 CAP1 | 1.15e-07 | 498 | 139 | 13 | 36634849 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TUT4 ISCA1 FXR2 POLR2B BAG5 YTHDC2 CPD GDI2 LETM1 ITPA ITPR2 RAB3GAP1 IARS2 TRMT6 FXR1 AKAP9 UTP11 AFG3L2 PDCD11 RPL3 YME1L1 GNL3 | 1.30e-07 | 1496 | 139 | 22 | 32877691 |
| Pubmed | 1.34e-07 | 202 | 139 | 9 | 24639526 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | IQGAP2 POLR2B POLR2G POLR1C DARS1 SMC2 GDI2 ITPA EEF1A2 IARS2 FXR1 UBR5 NUP210 AFG3L2 CDC5L ASCC3 RPL3 YME1L1 GNL3 TPI1 | 1.49e-07 | 1257 | 139 | 20 | 37317656 |
| Pubmed | MYH9 DARS1 SMC2 GDI2 LETM1 EEF1A2 IARS2 BOD1L1 EEA1 CDC5L ASCC3 SEPTIN7 RPL3 GNL3 LRRFIP1 TPI1 | 1.68e-07 | 809 | 139 | 16 | 32129710 | |
| Pubmed | 2.23e-07 | 282 | 139 | 10 | 23667531 | ||
| Pubmed | MYH9 FXR2 DOCK8 EML4 BAG5 DARS1 CPD ITPR2 FXR1 KIF3B KIF15 UBR5 NUP210 PRKAG1 CDC5L ASCC3 YME1L1 GNL3 PLIN3 | 2.24e-07 | 1168 | 139 | 19 | 19946888 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | GINM1 ATR EML4 BAG5 GABARAPL2 CPD ACSF2 EEF1A2 DGLUCY IARS2 FXR1 MACF1 ATP11C EEA1 SEPTIN7 PRRC1 PLIN3 CAP1 | 2.61e-07 | 1061 | 139 | 18 | 33845483 |
| Pubmed | MYH9 REXO4 IQGAP2 FXR2 DARS1 YTHDC2 SMC2 PSIP1 PDCD11 TLN2 LSM2 CDC5L RPL3 GNL3 TPI1 | 2.63e-07 | 731 | 139 | 15 | 29298432 | |
| Pubmed | FXR2 BAG5 DARS1 EEF1A2 IARS2 FXR1 UBR5 GGCT CTCF PDCD11 MACF1 RPL3 YME1L1 PLIN3 | 2.81e-07 | 634 | 139 | 14 | 34591612 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH9 REXO4 MCPH1 FXR2 POLA1 EVPL GIMAP7 EEF1A2 ITPR2 TRMT6 PSIP1 ARID5B KRT20 LTA4H BOD1L1 | 2.87e-07 | 736 | 139 | 15 | 29676528 |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 2.88e-07 | 221 | 139 | 9 | 29991511 | |
| Pubmed | TEAD2 ATR EP400 TRMT6 AKAP9 PSIP1 UBR5 CDC5L PRRC1 CRBN TPI1 | 6.17e-07 | 396 | 139 | 11 | 26687479 | |
| Pubmed | POLR2B POLR1C DARS1 SMC2 UBR5 SIPA1L1 EEA1 CDC5L SEPTIN7 LRRFIP1 TPI1 | 6.64e-07 | 399 | 139 | 11 | 37536630 | |
| Pubmed | MYH9 MYH11 DARS1 YTHDC2 SMC2 EEF1A2 UBC CTCF KRT222 NUP210 PDCD11 KRT20 MACF1 LSM2 CDC5L RPL3 GNL3 TPI1 | 8.67e-07 | 1153 | 139 | 18 | 29845934 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | IQGAP2 POLA1 POLR2B POLR1C DARS1 YTHDC2 SMC2 RAB3GAP1 IARS2 FXR1 UBR5 PDCD11 ASCC3 YME1L1 | 9.75e-07 | 704 | 139 | 14 | 29955894 |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 1.42e-06 | 87 | 139 | 6 | 17148452 | |
| Pubmed | POLR2B BAG5 POLR2G POLR1C DARS1 GDI2 POLR3D FXR1 UBR5 GGCT AFG3L2 PRKAG1 LSM2 CDC5L ASCC3 RPL3 YME1L1 GNL3 TPI1 | 1.65e-06 | 1335 | 139 | 19 | 29229926 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | EP400 FXR2 POLR2B POLR2G YTHDC2 ITPR2 FXR1 UBR5 NUP210 ASCC3 RPL3 | 1.72e-06 | 440 | 139 | 11 | 34244565 |
| Pubmed | ANK2 FXR2 POLR2B POLR1C DARS1 YTHDC2 SMC2 GDI2 TRMT6 FXR1 UBR5 UTP11 PDCD11 LSM2 CDC5L GNL3 | 1.85e-06 | 971 | 139 | 16 | 33306668 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 2.12e-06 | 281 | 139 | 9 | 28706196 | |
| Pubmed | MYH9 POLR2B POLR1C EVPL SMC2 UBC PSIP1 GGCT NUP210 CDC5L RPL3 GNL3 TPI1 | 2.36e-06 | 652 | 139 | 13 | 31180492 | |
| Pubmed | 2.38e-06 | 285 | 139 | 9 | 32838362 | ||
| Pubmed | 2.73e-06 | 216 | 139 | 8 | 31519766 | ||
| Pubmed | EP400 SMC2 FXR1 PSIP1 CEP44 NUP210 AFG3L2 CRYBG1 BOD1L1 CDC5L ASCC3 | 3.17e-06 | 469 | 139 | 11 | 27634302 | |
| Pubmed | 3.20e-06 | 100 | 139 | 6 | 10048485 | ||
| Pubmed | MYH9 TUT4 ANK2 SYN3 FXR2 APBA1 ADGRL1 DARS1 RAB3GAP1 SIPA1L1 AFG3L2 MACF1 TLN2 SEPTIN7 CAP1 LRRFIP1 TPI1 | 3.26e-06 | 1139 | 139 | 17 | 36417873 | |
| Pubmed | 3.39e-06 | 101 | 139 | 6 | 26949739 | ||
| Pubmed | Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus. | 3.76e-06 | 159 | 139 | 7 | 34578187 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH9 IQGAP2 FXR2 EML4 POLR2B POLR1C GABARAPL2 SMC2 EEF1A2 PHYH EIF2D UBR5 LTA4H RASSF8 CDC5L SEPTIN7 RPL3 GNL3 | 3.92e-06 | 1284 | 139 | 18 | 17353931 |
| Pubmed | ANK2 POLR1C APBA1 DARS1 ZKSCAN5 EEF1A2 DGLUCY TARS3 UBC SIPA1L1 KRT222 ARID5B MACF1 TLN2 RAPGEF2 SEPTIN7 YME1L1 LRRFIP1 | 3.96e-06 | 1285 | 139 | 18 | 35914814 | |
| Pubmed | MYH9 REXO4 POLR1C DARS1 YTHDC2 CTCF UTP11 PDCD11 RPL3 GNL3 TPI1 | 4.19e-06 | 483 | 139 | 11 | 36912080 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MYH9 MCPH1 ATR EP400 POLR2B APTX POLR1C SMC2 PSIP1 CTCF AFG3L2 ARID5B PDCD11 QSER1 LSM2 CDC5L RPL3 GNL3 | 4.36e-06 | 1294 | 139 | 18 | 30804502 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | EML4 POLR2B YTHDC2 SMC2 ITPR2 EIF2D FXR1 MS4A1 NUP210 ASCC3 YME1L1 TPI1 REV1 | 5.17e-06 | 701 | 139 | 13 | 30196744 |
| Pubmed | POLR1C EEF1A2 FXR1 NANS SIPA1L1 NUP210 PDCD11 SEPTIN7 YME1L1 GNL3 | 5.52e-06 | 403 | 139 | 10 | 35253629 | |
| Pubmed | 6.29e-06 | 242 | 139 | 8 | 34011540 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH9 MYH11 FXR2 POLR2B DARS1 GABARAPL2 FXR1 PSIP1 UTP11 PDCD11 CDC5L KLHDC4 RPL3 GNL3 LRRFIP1 | 6.52e-06 | 949 | 139 | 15 | 36574265 |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 7.23e-06 | 327 | 139 | 9 | 15592455 | |
| Pubmed | MYH9 REXO4 FXR2 POLR1C EVPL DARS1 SMC2 FXR1 PSIP1 CTCF NUP210 PDCD11 CDC5L RPL3 | 8.18e-06 | 847 | 139 | 14 | 35850772 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | EVPL DARS1 YTHDC2 GDI2 ITPR2 PSIP1 SIPA1L1 PDCD11 SEPTIN7 PRRC1 GNL3 CAP1 TPI1 | 8.21e-06 | 732 | 139 | 13 | 34732716 |
| Pubmed | 8.21e-06 | 251 | 139 | 8 | 27507650 | ||
| Pubmed | 8.56e-06 | 334 | 139 | 9 | 30425250 | ||
| Pubmed | REXO4 EP400 POLR2B APTX POLR1C YTHDC2 ZNF800 ZKSCAN1 CTCF FGD4 SIPA1L1 AFG3L2 PDCD11 CRYBG1 MACF1 ASCC3 YME1L1 GNL3 MPP7 | 8.57e-06 | 1497 | 139 | 19 | 31527615 | |
| Pubmed | 8.76e-06 | 119 | 139 | 6 | 23508102 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | FXR2 POLR2B POLR1C CPD GDI2 IARS2 EIF2D UBR5 NANS SIPA1L1 CEP152 RASSF8 SEPTIN7 GNL3 | 8.86e-06 | 853 | 139 | 14 | 28718761 |
| Pubmed | 9.71e-06 | 430 | 139 | 10 | 32581705 | ||
| Pubmed | 9.87e-06 | 340 | 139 | 9 | 29478914 | ||
| Pubmed | 9.87e-06 | 340 | 139 | 9 | 24332808 | ||
| Pubmed | A Y2H-seq approach defines the human protein methyltransferase interactome. | 1.03e-05 | 342 | 139 | 9 | 23455924 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYH9 FXR2 POLA1 BAG5 YTHDC2 DIPK2A FXR1 AKAP9 UBR5 UTP11 ZNF746 NUP210 ASCC3 | 1.12e-05 | 754 | 139 | 13 | 33060197 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH9 MYH11 DARS1 GDI2 UBR5 GGCT NUP210 SEPTIN7 RPL3 YME1L1 CAP1 TPI1 | 1.21e-05 | 647 | 139 | 12 | 26618866 |
| Pubmed | 1.25e-05 | 191 | 139 | 7 | 33762435 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH9 FXR2 POLA1 BAG5 POLR2G POLR1C YTHDC2 UBR5 SIPA1L1 AFG3L2 PRKAG1 LSM2 ASCC3 CRBN MPP7 | 1.28e-05 | 1005 | 139 | 15 | 19615732 |
| Pubmed | FGF11 induced by hypoxia interacts with HIF-1α and enhances its stability. | 1.33e-05 | 128 | 139 | 6 | 28027390 | |
| Pubmed | DOCK8 BAG5 LETM1 AKAP9 UBR5 SIPA1L1 CEP152 RASSF8 RAPGEF2 MPP7 | 1.33e-05 | 446 | 139 | 10 | 24255178 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.43e-05 | 271 | 139 | 8 | 32433965 | |
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 1.46e-05 | 37 | 139 | 4 | 27565344 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18790697 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 20007545 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21072162 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 11857508 | ||
| Pubmed | Talin2 binds to non-muscle myosin IIa and regulates cell attachment and fibronectin secretion. | 1.59e-05 | 2 | 139 | 2 | 39215026 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 10196376 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17897937 | ||
| Pubmed | Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2. | 1.59e-05 | 2 | 139 | 2 | 11735223 | |
| Pubmed | The Male Abnormal Gene Family 21 (Mab21) Members Regulate Eye Development. | 1.59e-05 | 2 | 139 | 2 | 27558071 | |
| Pubmed | Genomic cloning and chromosomal localization of the mouse Mab21l2 locus. | 1.59e-05 | 2 | 139 | 2 | 10516425 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15893736 | ||
| Pubmed | MYH9 FXR2 POLR2B GABARAPL2 CPD PSIP1 UBR5 GGCT NUP210 AFG3L2 PDCD11 MACF1 BOD1L1 EEA1 SEPTIN7 RPL3 GNL3 | 1.77e-05 | 1297 | 139 | 17 | 33545068 | |
| Pubmed | 1.83e-05 | 463 | 139 | 10 | 34901782 | ||
| Interaction | KCTD13 interactions | MYH9 MYH11 ANK2 SYN3 IQGAP2 DOCK8 POLR1C ADGRL1 DARS1 YTHDC2 GABARAPL2 GDI2 LETM1 EEF1A2 ITPR2 TARS3 FXR1 FGD4 SIPA1L1 AFG3L2 MACF1 TLN2 CDC5L RAPGEF2 SEPTIN7 RPL3 CAP1 LRRFIP1 TPI1 | 6.97e-08 | 1394 | 139 | 29 | int:KCTD13 |
| Interaction | SIRT7 interactions | MYH9 REXO4 ATR FXR2 POLA1 YTHDC2 GDI2 IARS2 FXR1 UBR5 CTCF NUP210 PDCD11 MACF1 LTA4H ASCC3 RPL3 GNL3 CAP1 | 8.81e-07 | 744 | 139 | 19 | int:SIRT7 |
| Interaction | TRIM52 interactions | 3.97e-06 | 133 | 139 | 8 | int:TRIM52 | |
| Interaction | SOX2 interactions | REXO4 EP400 BAG5 EVPL DARS1 YTHDC2 SMC2 GDI2 ITPR2 PSIP1 UBR5 CTCF SIPA1L1 ARID5B PDCD11 MACF1 BOD1L1 QSER1 LSM2 ASCC3 SEPTIN7 RPL3 PRRC1 GNL3 CAP1 TPI1 | 4.17e-06 | 1422 | 139 | 26 | int:SOX2 |
| Interaction | ATG16L1 interactions | EML4 POLR2B DARS1 YTHDC2 GABARAPL2 CCDC168 SMC2 ITPR2 EIF2D FXR1 KIF15 MS4A1 CEP44 SIPA1L1 KRT222 NUP210 AFG3L2 CEP152 ASCC3 RPL3 YME1L1 TPI1 REV1 | 4.44e-06 | 1161 | 139 | 23 | int:ATG16L1 |
| Interaction | STIP1 interactions | DOCK8 EML4 POLA1 GRK4 POLR2B BAG5 DARS1 SMC2 NPHP4 GDI2 ITPA FXR1 NUP210 PDCD11 CDC5L ASCC3 SEPTIN7 RPL3 GNL3 CAP1 TPI1 | 5.50e-06 | 1006 | 139 | 21 | int:STIP1 |
| Interaction | USP47 interactions | 6.96e-06 | 190 | 139 | 9 | int:USP47 | |
| Interaction | BRD7 interactions | MYH9 FXR2 POLR1C YTHDC2 SMC2 STN1 EEF1A2 TRMT6 FXR1 AFG3L2 PDCD11 CDC5L ASCC3 RPL3 YME1L1 GNL3 | 8.48e-06 | 637 | 139 | 16 | int:BRD7 |
| Interaction | MOB3C interactions | POLR2B POLR1C DARS1 SMC2 UBR5 SIPA1L1 EEA1 CDC5L SEPTIN7 CABCOCO1 LRRFIP1 TPI1 | 8.57e-06 | 364 | 139 | 12 | int:MOB3C |
| Interaction | PLEC interactions | MYH9 ATR BAG5 SMC2 NPHP4 UBC FGD4 UTP11 KRT222 MACF1 QSER1 CDC5L RAPGEF2 | 9.05e-06 | 430 | 139 | 13 | int:PLEC |
| Interaction | FBXW7 interactions | MYH9 EP400 POLR2B POLR2G POLR1C DARS1 IARS2 FXR1 ZKSCAN1 MS4A1 GGCT CTCF NANS UTP11 AFG3L2 PRKAG1 MACF1 EEA1 LSM2 ASCC3 RPL3 YME1L1 GNL3 | 9.34e-06 | 1215 | 139 | 23 | int:FBXW7 |
| Interaction | ZNF598 interactions | MYH9 FXR2 DARS1 SMC2 GDI2 FXR1 GGCT CEP44 NUP210 ASCC3 SEPTIN7 CAP1 LRRFIP1 | 1.02e-05 | 435 | 139 | 13 | int:ZNF598 |
| Interaction | RNF123 interactions | MYH9 REXO4 MCPH1 FXR2 POLA1 EVPL GABARAPL2 GIMAP7 DIPK2A EEF1A2 ITPR2 UBC TRMT6 PSIP1 ARID5B KRT20 LTA4H BOD1L1 | 1.51e-05 | 824 | 139 | 18 | int:RNF123 |
| Interaction | KDM1A interactions | MYH9 MCPH1 EP400 EML4 ZGRF1 POLR2B AKAP9 KIF15 UBR5 CEP44 KRT222 ARID5B LTA4H CEP152 RASSF8 CDC5L ASCC3 KLHDC4 CRBN | 2.55e-05 | 941 | 139 | 19 | int:KDM1A |
| Interaction | LOXL2 interactions | MYH9 MYH11 FXR2 EVPL GDI2 FXR1 GGCT MACF1 EEA1 RPL3 CAP1 TPI1 | 2.79e-05 | 410 | 139 | 12 | int:LOXL2 |
| Interaction | PA2G4 interactions | 2.84e-05 | 284 | 139 | 10 | int:PA2G4 | |
| Interaction | GSK3B interactions | MYH9 APBA1 YTHDC2 GDI2 IARS2 FXR1 UBR5 GGCT SIPA1L1 ZNF746 PDCD11 MACF1 LTA4H CEP152 RASSF8 ASCC3 CRBN CAP1 | 3.00e-05 | 868 | 139 | 18 | int:GSK3B |
| Interaction | KCNA3 interactions | MYH9 ANK2 DARS1 YTHDC2 CPD SMC2 LETM1 SIPA1L1 AFG3L2 MACF1 TLN2 BOD1L1 ASCC3 SEPTIN7 RPL3 PLIN3 CAP1 MPP7 | 3.14e-05 | 871 | 139 | 18 | int:KCNA3 |
| Interaction | BAP1 interactions | MYH9 IQGAP2 FXR2 KDM5C POLR2B BAG5 DARS1 SMC2 GDI2 EEF1A2 FXR1 UBR5 MACF1 LTA4H EEA1 CDC5L ASCC3 SEPTIN7 RPL3 GNL3 PLIN3 CAP1 TPI1 | 3.25e-05 | 1314 | 139 | 23 | int:BAP1 |
| Interaction | HSP90AB1 interactions | MYH9 POLA1 POLR1C DARS1 GABARAPL2 NPHP4 IARS2 PSIP1 CTCF NANS ZNF746 AFG3L2 BOD1L1 CDC5L KLHDC4 RPL3 CRBN CAP1 REV1 | 3.35e-05 | 960 | 139 | 19 | int:HSP90AB1 |
| Interaction | DCTN2 interactions | FXR2 EML4 MAB21L2 SMC2 IARS2 FXR1 AKAP9 KIF15 CEP44 CEP152 CDC5L | 3.73e-05 | 356 | 139 | 11 | int:DCTN2 |
| Interaction | ZSCAN1 interactions | 3.83e-05 | 55 | 139 | 5 | int:ZSCAN1 | |
| Interaction | BIRC3 interactions | MBTPS1 MYH9 REXO4 ATR POLR2B DARS1 SMC2 GDI2 LETM1 IARS2 FXR1 PSIP1 GGCT NUP210 PDCD11 TLN2 EEA1 CDC5L SEPTIN7 RPL3 GNL3 CAP1 TPI1 | 4.10e-05 | 1334 | 139 | 23 | int:BIRC3 |
| Interaction | POLR3K interactions | 4.23e-05 | 92 | 139 | 6 | int:POLR3K | |
| Interaction | NAA40 interactions | MYH9 ANK2 EP400 DARS1 YTHDC2 EEF1A2 IARS2 PSIP1 CTCF CEP44 AFG3L2 MACF1 LTA4H BOD1L1 CDC5L RPL3 GNL3 PLIN3 TPI1 | 4.31e-05 | 978 | 139 | 19 | int:NAA40 |
| Interaction | CEBPB interactions | MYH9 POLA1 POLR2B POLR2G POLR1C DARS1 SMC2 GDI2 LETM1 EEF1A2 AKAP9 PSIP1 GGCT CTCF NANS SIPA1L1 LSM2 CDC5L SEPTIN7 RPL3 GNL3 PLIN3 CAP1 TPI1 | 4.85e-05 | 1443 | 139 | 24 | int:CEBPB |
| Interaction | CCDC8 interactions | EP400 DARS1 YTHDC2 SMC2 ITPR2 FXR1 UBR5 AFG3L2 ARID5B PDCD11 MACF1 EEA1 ASCC3 RPL3 TPI1 | 4.87e-05 | 656 | 139 | 15 | int:CCDC8 |
| Interaction | EFTUD2 interactions | MYH9 FXR2 EML4 POLA1 BAG5 POLR1C DARS1 SMC2 LETM1 EEF1A2 FXR1 PSIP1 UBR5 GGCT ZNF746 AFG3L2 PRKAG1 MACF1 LSM2 CDC5L RPL3 GNL3 PLIN3 LRRFIP1 | 5.17e-05 | 1449 | 139 | 24 | int:EFTUD2 |
| Interaction | PFN1 interactions | MYH9 ANK2 DOCK8 EEF1A2 KIF3B AKAP9 KIF15 CEP44 MACF1 BOD1L1 CEP152 CAP1 TPI1 | 5.25e-05 | 509 | 139 | 13 | int:PFN1 |
| Interaction | FZR1 interactions | TEAD2 ANK2 MCPH1 FXR2 POLR2B POLR1C DARS1 YTHDC2 SMC2 GDI2 TRMT6 FXR1 UBR5 C7orf25 UTP11 PDCD11 LSM2 CDC5L RPL3 GNL3 MYBPC2 | 5.34e-05 | 1172 | 139 | 21 | int:FZR1 |
| Interaction | G3BP1 interactions | FXR2 POLR2B MAB21L2 UBC FXR1 SIPA1L1 NUP210 AFG3L2 PDCD11 CRYBG1 MACF1 LSM2 CDC5L ASCC3 RPL3 GNL3 CAP1 | 6.37e-05 | 835 | 139 | 17 | int:G3BP1 |
| Interaction | POLR3H interactions | 6.40e-05 | 99 | 139 | 6 | int:POLR3H | |
| Interaction | MYH9 interactions | MYH9 MYH11 EML4 BAG5 SMC2 NPHP4 LETM1 ITPR2 IARS2 UBC FXR1 CTCF MACF1 CDC5L SEPTIN7 LRRFIP1 | 6.54e-05 | 754 | 139 | 16 | int:MYH9 |
| Interaction | SPDL1 interactions | 6.79e-05 | 315 | 139 | 10 | int:SPDL1 | |
| Interaction | CHD4 interactions | TEAD2 MYH9 REXO4 MCPH1 ATR FXR2 EML4 MAB21L2 SMC2 NPHP4 PSIP1 ZKSCAN1 AFG3L2 PDCD11 CDC5L RPL3 GNL3 LRRFIP1 | 8.16e-05 | 938 | 139 | 18 | int:CHD4 |
| Interaction | MEN1 interactions | MYH9 REXO4 EP400 FXR2 POLA1 POLR2B POLR1C DARS1 SMC2 ITPR2 FXR1 PSIP1 UBR5 CTCF NUP210 PDCD11 BOD1L1 QSER1 RPL3 | 8.48e-05 | 1029 | 139 | 19 | int:MEN1 |
| Interaction | CDC5L interactions | MYH9 ATR DOCK8 BAG5 MAB21L2 SMC2 EIF2D FXR1 AKAP9 UBR5 ZNF746 MACF1 TLN2 LSM2 CDC5L SEPTIN7 RPL3 | 8.50e-05 | 855 | 139 | 17 | int:CDC5L |
| Interaction | GSK3A interactions | FXR2 YTHDC2 FXR1 AKAP9 UBR5 GGCT SIPA1L1 CRYBG1 MACF1 CEP152 RASSF8 ASCC3 | 9.15e-05 | 464 | 139 | 12 | int:GSK3A |
| Interaction | FERMT1 interactions | 9.61e-05 | 35 | 139 | 4 | int:FERMT1 | |
| Interaction | ENO1 interactions | MYH9 MYH11 MCPH1 ATR POLA1 SMC2 ITPA FXR1 PSIP1 UBR5 COL14A1 QSER1 ASCC3 SEPTIN7 TPI1 | 1.02e-04 | 701 | 139 | 15 | int:ENO1 |
| Interaction | FLOT1 interactions | TEAD2 MYH9 ANK2 EP400 POLR2B IARS2 AFG3L2 MACF1 BOD1L1 RASSF8 SEPTIN7 MPP7 | 1.14e-04 | 475 | 139 | 12 | int:FLOT1 |
| Interaction | VCP interactions | MYH9 SYN3 IQGAP2 EML4 POLR2B BAG5 POLR1C EEF1A2 RAB3GAP1 UBC FXR1 UBR5 ZBTB25 PRKAG1 KRT20 EEA1 LSM2 SEPTIN7 RPL3 CRBN CAP1 LRRFIP1 TPI1 | 1.24e-04 | 1435 | 139 | 23 | int:VCP |
| Interaction | IFI16 interactions | REXO4 FXR2 POLR2B POLR1C YTHDC2 TRMT6 FXR1 CTCF UTP11 PDCD11 CDC5L ASCC3 RPL3 GNL3 LRRFIP1 | 1.25e-04 | 714 | 139 | 15 | int:IFI16 |
| Interaction | NANOG interactions | TEAD2 EP400 POLR2B TRMT6 FXR1 AKAP9 PSIP1 ARID5B QSER1 CRBN GNL3 TPI1 | 1.28e-04 | 481 | 139 | 12 | int:NANOG |
| Interaction | PELO interactions | 1.29e-04 | 161 | 139 | 7 | int:PELO | |
| Interaction | SNCA interactions | MYH9 SYN3 IQGAP2 FXR2 BAG5 DARS1 SMC2 EEF1A2 FXR1 PSIP1 MACF1 TLN2 SEPTIN7 PLIN3 CAP1 | 1.29e-04 | 716 | 139 | 15 | int:SNCA |
| Interaction | DDRGK1 interactions | MYH9 REXO4 MYH11 ATR FXR2 EML4 DARS1 YTHDC2 MAB21L2 SMC2 TARS3 FXR1 PSIP1 CTCF AFG3L2 PDCD11 CDC5L RPL3 YME1L1 GNL3 TPI1 | 1.31e-04 | 1249 | 139 | 21 | int:DDRGK1 |
| Interaction | POLR1A interactions | 1.47e-04 | 220 | 139 | 8 | int:POLR1A | |
| Interaction | NAA38 interactions | 1.48e-04 | 39 | 139 | 4 | int:NAA38 | |
| Interaction | HECTD1 interactions | REXO4 IQGAP2 FXR2 POLR2B POLR1C DARS1 YTHDC2 SMC2 UBC FXR1 PSIP1 PDCD11 MACF1 CDC5L ASCC3 YME1L1 GNL3 LRRFIP1 | 1.49e-04 | 984 | 139 | 18 | int:HECTD1 |
| Interaction | USP14 interactions | MYH9 DARS1 CCDC92 ITPA EEF1A2 UBC FXR1 PSIP1 KIF15 MACF1 GNL3 LRRFIP1 | 1.50e-04 | 489 | 139 | 12 | int:USP14 |
| Interaction | TNFAIP1 interactions | 1.60e-04 | 74 | 139 | 5 | int:TNFAIP1 | |
| Interaction | AURKAIP1 interactions | 1.60e-04 | 284 | 139 | 9 | int:AURKAIP1 | |
| Interaction | ACTB interactions | MYH9 MYH11 EP400 IQGAP2 ACSF2 NPHP4 GDI2 EEF1A2 FXR1 P2RX7 FGD4 SIPA1L1 MACF1 LSM2 RASSF8 CDC5L RPL3 CAP1 LRRFIP1 | 1.65e-04 | 1083 | 139 | 19 | int:ACTB |
| Interaction | SHANK3 interactions | ANK2 ADGRL1 NPHP4 FXR1 KIF3B KIF15 MACF1 TLN2 RAPGEF2 SEPTIN7 RPL3 CAP1 | 1.71e-04 | 496 | 139 | 12 | int:SHANK3 |
| Interaction | MAP3K14 interactions | 1.74e-04 | 169 | 139 | 7 | int:MAP3K14 | |
| Interaction | MYH10 interactions | 1.98e-04 | 359 | 139 | 10 | int:MYH10 | |
| Interaction | MAPRE3 interactions | 1.99e-04 | 230 | 139 | 8 | int:MAPRE3 | |
| Interaction | PGK1 interactions | 2.36e-04 | 367 | 139 | 10 | int:PGK1 | |
| Interaction | AGR2 interactions | MYH9 MYH11 DARS1 GDI2 EEF1A2 IARS2 AKAP9 PSIP1 GGCT NANS MOV10L1 MACF1 LTA4H EEA1 RPL3 CAP1 TPI1 | 2.44e-04 | 934 | 139 | 17 | int:AGR2 |
| Interaction | CEP63 interactions | 2.47e-04 | 179 | 139 | 7 | int:CEP63 | |
| Interaction | CYFIP1 interactions | 2.59e-04 | 303 | 139 | 9 | int:CYFIP1 | |
| Interaction | TNIP1 interactions | MYH9 MYH11 FXR2 POLR2B DARS1 GABARAPL2 UBC FXR1 PSIP1 GGCT ZBTB25 UTP11 CEP44 PDCD11 CEP152 CDC5L KLHDC4 RPL3 GNL3 LRRFIP1 | 2.60e-04 | 1217 | 139 | 20 | int:TNIP1 |
| Interaction | C9orf72 interactions | SYN3 IQGAP2 POLR2B POLR2G POLR1C DARS1 SMC2 GDI2 ITPA EEF1A2 IARS2 FXR1 UBR5 NUP210 AFG3L2 CDC5L ASCC3 RPL3 YME1L1 GNL3 TPI1 | 2.77e-04 | 1319 | 139 | 21 | int:C9orf72 |
| Interaction | PPP5D1P interactions | 2.81e-04 | 4 | 139 | 2 | int:PPP5D1P | |
| Interaction | PHC1P1 interactions | 2.81e-04 | 4 | 139 | 2 | int:PHC1P1 | |
| Interaction | SYNGAP1 interactions | 2.85e-04 | 307 | 139 | 9 | int:SYNGAP1 | |
| Interaction | CHMP4C interactions | MYH11 POLR1C DARS1 GDI2 EEF1A2 IARS2 FXR1 NUP210 PDCD11 MACF1 CDC5L RPL3 GNL3 CAP1 | 2.89e-04 | 687 | 139 | 14 | int:CHMP4C |
| Interaction | FNBP1 interactions | 2.98e-04 | 131 | 139 | 6 | int:FNBP1 | |
| Interaction | RNF2 interactions | EP400 FXR2 KDM5C POLR2B POLR2G SOWAHA AKAP9 UBR5 AFG3L2 PDCD11 EEA1 CDC5L RPL3 GNL3 LRRFIP1 TPI1 | 3.18e-04 | 866 | 139 | 16 | int:RNF2 |
| Interaction | SUB1 interactions | 3.22e-04 | 247 | 139 | 8 | int:SUB1 | |
| Interaction | MACROH2A1 interactions | TEAD2 MYH9 MYH11 EML4 POLR2B GDI2 PSIP1 CTCF CDC5L RPL3 LRRFIP1 | 3.41e-04 | 458 | 139 | 11 | int:MACROH2A1 |
| Interaction | STK32C interactions | 3.41e-04 | 87 | 139 | 5 | int:STK32C | |
| Interaction | ZC3H18 interactions | MYH9 REXO4 IQGAP2 FXR2 DARS1 YTHDC2 SMC2 PSIP1 CTCF PDCD11 TLN2 LSM2 CDC5L RPL3 GNL3 TPI1 | 3.65e-04 | 877 | 139 | 16 | int:ZC3H18 |
| Interaction | TRIM56 interactions | 3.79e-04 | 137 | 139 | 6 | int:TRIM56 | |
| Interaction | FUOM interactions | 3.90e-04 | 21 | 139 | 3 | int:FUOM | |
| Interaction | PPA1 interactions | 3.90e-04 | 193 | 139 | 7 | int:PPA1 | |
| Interaction | NFX1 interactions | MYH9 FXR2 APBA1 DARS1 YTHDC2 EEF1A2 FXR1 UTP11 ASCC3 RPL3 GNL3 | 3.94e-04 | 466 | 139 | 11 | int:NFX1 |
| Interaction | NUP43 interactions | REXO4 EP400 POLA1 KDM5C CCDC168 PSIP1 UBR5 CTCF PDCD11 BOD1L1 RAPGEF2 RPL3 GNL3 | 3.96e-04 | 625 | 139 | 13 | int:NUP43 |
| Interaction | TRAP1 interactions | MYH9 MCPH1 NPHP4 LETM1 IARS2 FXR1 UBR5 NANS AFG3L2 LTA4H CDC5L | 4.09e-04 | 468 | 139 | 11 | int:TRAP1 |
| Interaction | BTF3 interactions | MYH9 ANK2 IQGAP2 FXR2 POLA1 POLR2B SMC2 ITPR2 FXR1 SIPA1L1 PRKAG1 ATP11C ASCC3 RPL3 TPI1 | 4.18e-04 | 799 | 139 | 15 | int:BTF3 |
| Interaction | RPS6KL1 interactions | 4.21e-04 | 51 | 139 | 4 | int:RPS6KL1 | |
| Interaction | H2BC4 interactions | 4.42e-04 | 259 | 139 | 8 | int:H2BC4 | |
| Interaction | VIM interactions | MYH9 MCPH1 FXR2 POLR1C NPHP4 FXR1 PSIP1 KIF15 UBR5 CEP44 KRT20 CRYBG1 RASSF8 CDC5L ASCC3 | 4.46e-04 | 804 | 139 | 15 | int:VIM |
| Interaction | CAND1 interactions | TUT4 FXR2 POLR2B ZNF407 YTHDC2 EEF1A2 TRMT6 FXR1 CTCF ZNF746 ARID5B PDCD11 CDC5L ASCC3 RPL3 GNL3 | 4.51e-04 | 894 | 139 | 16 | int:CAND1 |
| Interaction | DOT1L interactions | MYH9 REXO4 FXR2 POLR1C EVPL DARS1 SMC2 FXR1 PSIP1 CTCF NUP210 PDCD11 CDC5L RPL3 GNL3 | 4.63e-04 | 807 | 139 | 15 | int:DOT1L |
| Interaction | ANOS1 interactions | 4.76e-04 | 143 | 139 | 6 | int:ANOS1 | |
| Interaction | LGR4 interactions | 4.77e-04 | 262 | 139 | 8 | int:LGR4 | |
| Interaction | CCDC92 interactions | 4.88e-04 | 53 | 139 | 4 | int:CCDC92 | |
| Interaction | SEPTIN10 interactions | 4.94e-04 | 144 | 139 | 6 | int:SEPTIN10 | |
| Interaction | RAB22A interactions | 5.14e-04 | 23 | 139 | 3 | int:RAB22A | |
| Interaction | DIABLO interactions | 5.67e-04 | 269 | 139 | 8 | int:DIABLO | |
| Interaction | U2AF2 interactions | MYH9 STAC3 DARS1 SMC2 GDI2 UBR5 CTCF CDC5L SEPTIN7 CRBN CAP1 LRRFIP1 TPI1 | 5.80e-04 | 651 | 139 | 13 | int:U2AF2 |
| Interaction | PDP2 interactions | 5.84e-04 | 24 | 139 | 3 | int:PDP2 | |
| Interaction | ADARB1 interactions | MYH9 REXO4 ANK2 FXR2 YTHDC2 SMC2 ZNF800 CTCF PDCD11 RPL3 GNL3 | 5.89e-04 | 489 | 139 | 11 | int:ADARB1 |
| Interaction | POLR1G interactions | REXO4 EP400 IQGAP2 POLR2B POLR2G POLR1C POLR3D CTCF PDCD11 RPL3 GNL3 | 5.89e-04 | 489 | 139 | 11 | int:POLR1G |
| Interaction | FGD5 interactions | 5.93e-04 | 207 | 139 | 7 | int:FGD5 | |
| Interaction | MSH6 interactions | 5.95e-04 | 271 | 139 | 8 | int:MSH6 | |
| Interaction | FKBP5 interactions | 6.08e-04 | 414 | 139 | 10 | int:FKBP5 | |
| Interaction | FLT4 interactions | 6.10e-04 | 272 | 139 | 8 | int:FLT4 | |
| GeneFamily | RNA polymerase subunits | 8.56e-06 | 29 | 82 | 4 | 726 | |
| GeneFamily | EF-hand domain containing|Plakins | 5.59e-04 | 8 | 82 | 2 | 939 | |
| GeneFamily | UPF1 like RNA helicases | 1.09e-03 | 11 | 82 | 2 | 1169 | |
| GeneFamily | AT-rich interaction domain containing | 2.05e-03 | 15 | 82 | 2 | 418 | |
| GeneFamily | Myosin heavy chains | 2.05e-03 | 15 | 82 | 2 | 1098 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MYH9 TUT4 THEMIS ATR EP400 DOCK8 EML4 POLR2B DARS1 YTHDC2 GIMAP7 STN1 ITPR2 ZNF800 UBC AKAP9 PSIP1 UBR5 CTCF NUP210 CRYBG1 MACF1 BOD1L1 ASCC3 SEPTIN7 YME1L1 CRBN CAP1 LRRFIP1 | 9.53e-10 | 1492 | 139 | 29 | M40023 |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 9.56e-08 | 195 | 139 | 10 | M13736 | |
| Coexpression | RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN | DARS1 SMC2 GDI2 PHYH IARS2 FXR1 PSIP1 KIF15 GGCT LTA4H RPL3 TPI1 | 6.61e-07 | 368 | 139 | 12 | M1859 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | EP400 POLA1 POLR2B APBA1 DARS1 SMC2 NPHP4 GDI2 POLR3D PSIP1 P2RX7 MS4A1 CTCF NUP210 KRT20 LTA4H RASSF8 YME1L1 PLIN3 CAP1 LRRFIP1 MYBPC2 | 4.29e-06 | 1394 | 139 | 22 | M9585 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | ISCA1 IQGAP2 POLR2B POLR1C DARS1 CPD SMC2 GDI2 ITPA ITPR2 PHYH EIF2D PSIP1 CTCF PRKAG1 CDC5L RAPGEF2 SEPTIN7 YME1L1 CRBN GNL3 TPI1 | 4.54e-06 | 1399 | 139 | 22 | M535 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 4.90e-06 | 177 | 139 | 8 | M39245 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | POLR1C DARS1 SMC2 POLR3D FXR1 KIF15 GGCT NUP210 PDCD11 LTA4H LSM2 GNL3 PLIN3 TPI1 | 4.97e-06 | 612 | 139 | 14 | M4772 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 5.54e-06 | 180 | 139 | 8 | M8239 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ISCA1 EML4 DARS1 CPD ACSF2 STN1 ITPR2 UBR5 ZBTB25 C7orf25 UTP11 NUP210 AFG3L2 AACS MACF1 EEA1 ASCC3 RAPGEF2 PLIN3 CAP1 | 6.66e-06 | 1215 | 139 | 20 | M41122 |
| Coexpression | GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_DN | 1.15e-05 | 199 | 139 | 8 | M8148 | |
| Coexpression | GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_DN | 1.15e-05 | 199 | 139 | 8 | M7129 | |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN | 1.15e-05 | 199 | 139 | 8 | M6199 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP | 1.20e-05 | 200 | 139 | 8 | M4613 | |
| Coexpression | GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP | 1.20e-05 | 200 | 139 | 8 | M4830 | |
| Coexpression | GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_DN | 1.20e-05 | 200 | 139 | 8 | M7829 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN | 2.41e-05 | 160 | 139 | 7 | M8664 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN | 2.93e-05 | 165 | 139 | 7 | M353 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP | 3.05e-05 | 166 | 139 | 7 | M344 | |
| Coexpression | DITTMER_PTHLH_TARGETS_DN | 3.58e-05 | 70 | 139 | 5 | M18667 | |
| Coexpression | LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q | 3.67e-05 | 116 | 139 | 6 | M8411 | |
| Coexpression | GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_UP | 9.00e-05 | 197 | 139 | 7 | M9589 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN | 9.29e-05 | 198 | 139 | 7 | M4202 | |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_DN | 9.59e-05 | 199 | 139 | 7 | M3585 | |
| Coexpression | GSE42724_NAIVE_VS_B1_BCELL_DN | 9.59e-05 | 199 | 139 | 7 | M9796 | |
| Coexpression | GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN | 9.89e-05 | 200 | 139 | 7 | M3276 | |
| Coexpression | GSE17721_CTRL_VS_CPG_8H_BMDC_DN | 9.89e-05 | 200 | 139 | 7 | M3768 | |
| Coexpression | GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN | 9.89e-05 | 200 | 139 | 7 | M5128 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP | 9.89e-05 | 200 | 139 | 7 | M6618 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TREG_DN | 9.89e-05 | 200 | 139 | 7 | M5738 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | MYH9 THEMIS DOCK8 GIMAP7 STN1 UBC PSIP1 NUP210 MACF1 LSM2 SEPTIN7 RPL3 YME1L1 CAP1 LRRFIP1 | 1.03e-04 | 911 | 139 | 15 | M40038 |
| Coexpression | OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP | 1.07e-04 | 349 | 139 | 9 | M283 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | TEAD2 ATR POLA1 BAG5 DARS1 CPD COLGALT2 SMC2 GDI2 DIPK2A TRMT6 KIF15 UBR5 SIPA1L1 ZNF746 CEP152 CDC5L YME1L1 | 1.67e-04 | 1290 | 139 | 18 | M80 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TUT4 ATR POLR2B RAB3GAP1 FXR1 AKAP9 UBR5 CTCF SIPA1L1 ARID5B MACF1 ASCC3 RAPGEF2 LRRFIP1 | 1.90e-04 | 856 | 139 | 14 | M4500 |
| Coexpression | SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM | 2.24e-04 | 161 | 139 | 6 | M5075 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | THEMIS EML4 POLR1C YTHDC2 ZSWIM9 PSIP1 MS4A1 CDC5L ASCC3 LRRFIP1 | 2.27e-04 | 474 | 139 | 10 | M40991 |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 2.48e-04 | 164 | 139 | 6 | M19957 | |
| Coexpression | GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN | 2.56e-04 | 165 | 139 | 6 | M8992 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TUT4 ANK2 MCPH1 ATR POLA1 ZGRF1 GRK4 SMC2 ZSWIM9 ZNF800 IARS2 TRMT6 AKAP9 PSIP1 KIF15 GGCT ZBTB25 MACF1 ATP11C BOD1L1 QSER1 CDC5L RAPGEF2 SEPTIN7 GNL3 | 4.34e-07 | 1257 | 137 | 25 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TUT4 ANK2 IQGAP2 POLA1 GRK4 STAC3 CCDC92 SMC2 RANBP17 ZSWIM9 ZNF800 TARS3 IARS2 AKAP9 PSIP1 KIF15 NUP210 MACF1 ATP11C BOD1L1 QSER1 RSPH9 | 1.17e-06 | 1060 | 137 | 22 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TUT4 ANK2 MCPH1 ATR POLA1 ZGRF1 GRK4 SMC2 ZSWIM9 ZNF800 IARS2 TRMT6 AKAP9 PSIP1 KIF15 GGCT ZBTB25 KRT20 MACF1 ATP11C BOD1L1 QSER1 CDC5L RAPGEF2 SEPTIN7 GNL3 | 1.95e-06 | 1459 | 137 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ZGRF1 POLR2B BAG5 STAC3 ZNF407 SMC2 GDI2 ZKSCAN5 AKAP9 MACF1 BOD1L1 QSER1 RAPGEF2 YME1L1 RSPH9 MPP7 | 3.11e-06 | 629 | 137 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | MBTPS1 MYH9 TUT4 IQGAP2 DOCK8 AKAP9 ZKSCAN1 ASCC3 MPP7 LRRFIP1 | 7.73e-06 | 261 | 137 | 10 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ZGRF1 POLR2B BAG5 ZNF407 GDI2 KIF3B CTCF SIPA1L1 NUP210 MACF1 BOD1L1 CDC5L RAPGEF2 MPP7 | 3.16e-05 | 595 | 137 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | TUT4 ANK2 IQGAP2 POLA1 GRK4 STAC3 CCDC92 SMC2 RANBP17 ZSWIM9 ZNF800 TARS3 IARS2 AKAP9 PSIP1 KIF15 NUP210 MACF1 ATP11C BOD1L1 QSER1 CABCOCO1 RSPH9 | 3.57e-05 | 1414 | 137 | 23 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | IQGAP2 CPD SMC2 AKAP9 ZKSCAN1 COL14A1 ATP11C RASSF8 ASCC3 PRRC1 | 5.76e-05 | 330 | 137 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | MCPH1 ATR FXR2 POLA1 ZGRF1 DARS1 RANBP17 UBR5 GGCT NANS MOV10L1 NUP210 PDCD11 LSM2 KLHDC4 GNL3 | 5.89e-05 | 799 | 137 | 16 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | TUT4 MAB21L2 SMC2 ITPR2 DGLUCY GGCT ARID5B BOD1L1 QSER1 MAB21L1 | 5.90e-05 | 331 | 137 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.93e-05 | 152 | 137 | 7 | gudmap_developingKidney_e15.5_S-shaped body_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | TUT4 SYN3 POLA1 STAC3 LETM1 ZNF800 TRMT6 AKAP9 KIF15 UBR5 FGD4 MOV10L1 NUP210 BOD1L1 CDH7 RSPH9 GNL3 MPP7 | 6.82e-05 | 989 | 137 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | ATR POLA1 ZGRF1 GRK4 DARS1 YTHDC2 CCDC92 RALGAPA2 RANBP17 TARS3 IARS2 MOV10L1 NUP210 ATP11C LSM2 REV1 | 7.99e-05 | 820 | 137 | 16 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.44e-04 | 369 | 137 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.65e-04 | 375 | 137 | 10 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_1000 | MBTPS1 MYH9 MYH11 TUT4 DOCK8 EVPL CPD SMC2 AKAP9 FGD4 NUP210 KRT20 CRYBG1 MPP7 LRRFIP1 | 1.67e-04 | 784 | 137 | 15 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | ATR POLA1 ZGRF1 DARS1 YTHDC2 RANBP17 UBR5 GGCT NANS KRT222 MOV10L1 PDCD11 LSM2 GNL3 REV1 | 1.95e-04 | 795 | 137 | 15 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | MBTPS1 MYH9 IQGAP2 KDM5C CPD SMC2 AKAP9 ZKSCAN1 COL14A1 ASCC3 | 2.03e-04 | 385 | 137 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | MCPH1 POLA1 DARS1 RANBP17 UBR5 GGCT NANS NUP210 PDCD11 LSM2 GNL3 | 2.12e-04 | 463 | 137 | 11 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | ATR POLA1 POLR2B RANBP17 IARS2 UBR5 GGCT KRT222 MOV10L1 NUP210 PDCD11 LSM2 RSPH9 GNL3 REV1 | 2.38e-04 | 810 | 137 | 15 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_200 | 2.65e-04 | 88 | 137 | 5 | gudmap_developingKidney_e15.5_200_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 3.34e-04 | 201 | 137 | 7 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | TUT4 SMC2 ITPR2 DGLUCY AKAP9 GGCT MOV10L1 MACF1 BOD1L1 QSER1 MAB21L1 | 3.55e-04 | 492 | 137 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_500 | 3.60e-04 | 94 | 137 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.63e-04 | 339 | 137 | 9 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | TUT4 ATR GRK4 SMC2 ITPR2 IARS2 POLR3D FXR1 AKAP9 PSIP1 KIF15 GGCT MACF1 ATP11C BOD1L1 QSER1 RASSF8 SEPTIN7 GNL3 | 3.94e-04 | 1241 | 137 | 19 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 5.32e-04 | 156 | 137 | 6 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | MCPH1 ATR POLA1 DARS1 RANBP17 TRMT6 UBR5 GGCT NANS MOV10L1 NUP210 LSM2 KLHDC4 GNL3 | 5.34e-04 | 781 | 137 | 14 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | TUT4 MAB21L2 SMC2 ITPR2 DGLUCY AKAP9 GGCT MOV10L1 ARID5B MACF1 COL14A1 BOD1L1 QSER1 CDH7 RSPH9 MAB21L1 | 5.78e-04 | 978 | 137 | 16 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.81e-08 | 171 | 139 | 8 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-07 | 182 | 139 | 8 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | COPD-Lymphoid-T|COPD / Disease state, Lineage and Cell class | 1.94e-07 | 196 | 139 | 8 | 30e53b8050d2a041f855d0e39bbd8f923c64c489 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.27e-07 | 200 | 139 | 8 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-06 | 190 | 139 | 7 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.81e-06 | 196 | 139 | 7 | c647ce58de4c5bb4ceb1123690e637eae4ae1b82 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 2.90e-06 | 197 | 139 | 7 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.21e-06 | 200 | 139 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-05 | 168 | 139 | 6 | 32e4d82efaccf336d347e4063253c3635a3ec672 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.63e-05 | 171 | 139 | 6 | e1fe07652c10c37191d1471ddaea500f74269e0c | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 182 | 139 | 6 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 183 | 139 | 6 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 183 | 139 | 6 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.78e-05 | 188 | 139 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.87e-05 | 189 | 139 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 2.95e-05 | 190 | 139 | 6 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.95e-05 | 190 | 139 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.04e-05 | 191 | 139 | 6 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 3.13e-05 | 192 | 139 | 6 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | 3.13e-05 | 192 | 139 | 6 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.22e-05 | 193 | 139 | 6 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.32e-05 | 194 | 139 | 6 | 929b97eb0a4a88cd566f832d4959b8b8a34c46b4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.32e-05 | 194 | 139 | 6 | 4bcbea5dc0c91c51fbb6b0f7de1e47010c62812a | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_Tcm|COVID-19_Mild / Disease group, lineage and cell class | 3.32e-05 | 194 | 139 | 6 | 0aad8c7f356d54346af764e0cc4edce89c6daabb | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.32e-05 | 194 | 139 | 6 | 8c3c04770913724b4e93941b547402052ae352c2 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.32e-05 | 194 | 139 | 6 | 884b5c98a1fdc651d7f4a0fad2a5965859207abc | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 3.42e-05 | 195 | 139 | 6 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.42e-05 | 195 | 139 | 6 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.42e-05 | 195 | 139 | 6 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.42e-05 | 195 | 139 | 6 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.42e-05 | 195 | 139 | 6 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.52e-05 | 196 | 139 | 6 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.52e-05 | 196 | 139 | 6 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.62e-05 | 197 | 139 | 6 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | Mild|World / Condition, Lineage, Cell class and cell subclass | 3.62e-05 | 197 | 139 | 6 | 476b0d0389f9fcd4614f6bb1f494281f467f6730 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.72e-05 | 198 | 139 | 6 | 8a7897d98f5296745d9005a7cd777f0a2f78000d | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 3.83e-05 | 199 | 139 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-05 | 200 | 139 | 6 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Mesenchymal-Unfolded_protein_responsible_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 200 | 139 | 6 | 1b08c1be05e2a6a05d8ea35d9a745c4b1809a1b2 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD4+_Tcm|Bac-SEP / Disease, condition lineage and cell class | 3.93e-05 | 200 | 139 | 6 | fe0e0b25fbe2c7bad6bffef17f62bf346c83fc54 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Wif1_(Medial_habenular,_lateral_portion)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.15e-04 | 80 | 139 | 4 | da18df34b4f630fe4fe3110e3c3c3602aef92aab | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-04 | 155 | 139 | 5 | d10cf5e922dbd3ca46660404da5aca43f181fc19 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-04 | 162 | 139 | 5 | 45be019b50e3727fc9d3fad2ff78e74e4f2d746b | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-04 | 162 | 139 | 5 | fbb0cc2b1434a340dc35058b77c73ea61004c252 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 1.55e-04 | 162 | 139 | 5 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 163 | 139 | 5 | a763c1632d6465a1e753bdc8eadaf819d2b09e5e | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 163 | 139 | 5 | eaed783eecd07aafa5af844b63c9d816b4da99e4 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 1.64e-04 | 164 | 139 | 5 | 334f376350c9cf92611d0f75b2e18a102f4c116a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.79e-04 | 167 | 139 | 5 | 063ec29b32e40aaa138a691da3a79ee8eef0c2be | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.79e-04 | 167 | 139 | 5 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 168 | 139 | 5 | 69dd747be46e7fbcec571cddd6dee374b9c2507a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-04 | 170 | 139 | 5 | cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-04 | 170 | 139 | 5 | da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-04 | 170 | 139 | 5 | a0d6466e00bd3dc07f644ba3f87d5b421fd479d5 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.99e-04 | 171 | 139 | 5 | 1efce222989460bb59bd9fa955e7d9a60c73994c | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.99e-04 | 171 | 139 | 5 | 2991096336eea87740708360e34f84a00cb2eff2 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-04 | 174 | 139 | 5 | 99d7421ad5eafe7751ef90698a92f683aa33bca8 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-04 | 174 | 139 | 5 | 66555c610251ea04f968c258e312d720c18e7cde | |
| ToppCell | COPD-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 2.22e-04 | 175 | 139 | 5 | e773e330de36f8a0aa9398a176ed7edb5599c582 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.34e-04 | 177 | 139 | 5 | 95760841b3f085d38c4926b258a33563d93a2016 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-04 | 179 | 139 | 5 | ecea75c568911ff56939c9f67ab901497bd4356c | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 181 | 139 | 5 | 46de8c18e4ec8dc9d07f7c8cc7b5f48b9c613aae | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.59e-04 | 181 | 139 | 5 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.59e-04 | 181 | 139 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 182 | 139 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 182 | 139 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 182 | 139 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.73e-04 | 183 | 139 | 5 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.73e-04 | 183 | 139 | 5 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 184 | 139 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 184 | 139 | 5 | e7b9c69fc77040c5191ad8089697051e2589c30e | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 184 | 139 | 5 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 185 | 139 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 186 | 139 | 5 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 187 | 139 | 5 | b6ecf55014f246461bf1ca12f24cb4d046661fa4 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 187 | 139 | 5 | 91c8e93bde0d1d1a4e324b0acf2afda00f4fb3bf | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 187 | 139 | 5 | 9fb15f24b9b364b0c4704ec98aec236eaec5411c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 187 | 139 | 5 | e6afbaed352310a1cb49571a2aae18be1f533c9a | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 187 | 139 | 5 | 382db691eb0b3e089e816bed3d6699cc2d4e1bda | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD4_TCM|Int-URO / Disease, Lineage and Cell Type | 3.01e-04 | 187 | 139 | 5 | 9a137961d33c6b440f1e5ef40360a365e3c03ab2 | |
| ToppCell | LPS_only-Lymphocytic_NKT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-04 | 188 | 139 | 5 | bbe65b1c11c88ab62d8485cfc3a913ff9da89aad | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.09e-04 | 188 | 139 | 5 | 0ddc5dbe2fd905fee20c33d9845629e259faacd9 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.09e-04 | 188 | 139 | 5 | ef05d2fb17fd427d46d454e67073e0e1b45bb24c | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-04 | 188 | 139 | 5 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-04 | 188 | 139 | 5 | 63773854bf8430fb8229edb385b953a89833d08c | |
| ToppCell | (1)_T_CD4|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.16e-04 | 189 | 139 | 5 | 2298a96c53c5bd767e17554c50379b2d1ad8b5b0 | |
| ToppCell | (1)_T_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.16e-04 | 189 | 139 | 5 | fa6b85676b2b61483ae27720d0715dbfcbcfbdf9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-04 | 189 | 139 | 5 | b87d586a9570fa54f3e0c6bd4731c5badcaedae6 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.16e-04 | 189 | 139 | 5 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.16e-04 | 189 | 139 | 5 | ebaf722738c71d5f33f72341f801c6880f4aee14 | |
| ToppCell | facs-Pancreas-Endocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 189 | 139 | 5 | 010fdd70e9d0e21b856306a29ff877776a480319 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-04 | 189 | 139 | 5 | 823d6debd09e440ddf36c54af24a5f20e222a21e | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.16e-04 | 189 | 139 | 5 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-04 | 189 | 139 | 5 | 47c2b419b081d5bf75da5e3d9a0e05a70362dfe7 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.16e-04 | 189 | 139 | 5 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD4_TCM|Leuk-UTI / Disease, Lineage and Cell Type | 3.24e-04 | 190 | 139 | 5 | 5f8d606d2f465ddeae7451835f84b3f25a151d2a | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 3.24e-04 | 190 | 139 | 5 | 10bece40d980d37a01dae8ce887655bf9f93040c | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|IPF / Disease state, Lineage and Cell class | 3.24e-04 | 190 | 139 | 5 | e5d0186bfb416a3eda76ac12b9379650afb6f409 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 3.24e-04 | 190 | 139 | 5 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD8_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.32e-04 | 191 | 139 | 5 | f7a42a9d7493ea25cd8bd297c22e49e4bad7f0a4 | |
| Computational | Genes in the cancer module 419. | 1.76e-04 | 34 | 90 | 4 | MODULE_419 | |
| Computational | Neighborhood of PSMC1 | 1.85e-04 | 190 | 90 | 8 | MORF_PSMC1 | |
| Disease | fragile X syndrome (implicated_via_orthology) | 6.49e-05 | 3 | 138 | 2 | DOID:14261 (implicated_via_orthology) | |
| Disease | malignant pleural mesothelioma (implicated_via_orthology) | 6.49e-05 | 3 | 138 | 2 | DOID:7474 (implicated_via_orthology) | |
| Disease | Seckel syndrome 1 | 6.49e-05 | 3 | 138 | 2 | C4551474 | |
| Disease | orofacial cleft (is_implicated_in) | 4.49e-04 | 7 | 138 | 2 | DOID:0050567 (is_implicated_in) | |
| Disease | Profound Mental Retardation | 5.06e-04 | 139 | 138 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 5.06e-04 | 139 | 138 | 5 | C0025363 | |
| Disease | Mental deficiency | 5.06e-04 | 139 | 138 | 5 | C0917816 | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 5.87e-04 | 35 | 138 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 5.97e-04 | 8 | 138 | 2 | C0796250 | |
| Disease | anemia (phenotype), response to ribavirin | 7.65e-04 | 9 | 138 | 2 | EFO_0004272, GO_1901559 | |
| Disease | osteoarthritis, hip | 9.31e-04 | 92 | 138 | 4 | EFO_1000786 | |
| Disease | Intellectual Disability | 1.25e-03 | 447 | 138 | 8 | C3714756 | |
| Disease | obsolete_red blood cell distribution width | ISCA1 SYN3 ATR EP400 FXR2 DOCK8 ZNF407 ZNF800 ZKSCAN1 EEPD1 NUP210 PRKAG1 CRYBG1 ATP11C GNL3 | 1.63e-03 | 1347 | 138 | 15 | EFO_0005192 |
| Disease | Anemia, Hemolytic, Acquired | 1.64e-03 | 13 | 138 | 2 | C0002879 | |
| Disease | Anemia, Hemolytic | 1.64e-03 | 13 | 138 | 2 | C0002878 | |
| Disease | Anemia, Microangiopathic | 1.64e-03 | 13 | 138 | 2 | C0002889 | |
| Disease | Microangiopathic hemolytic anemia | 1.64e-03 | 13 | 138 | 2 | C0221021 | |
| Disease | serum selenium measurement | 1.98e-03 | 53 | 138 | 3 | EFO_0005266 | |
| Disease | Autosomal recessive primary microcephaly | 2.19e-03 | 15 | 138 | 2 | cv:C3711387 | |
| Disease | idiopathic pulmonary fibrosis | 2.44e-03 | 57 | 138 | 3 | EFO_0000768 | |
| Disease | shigellosis | 2.50e-03 | 16 | 138 | 2 | EFO_0005585 | |
| Disease | Romano-Ward Syndrome | 2.50e-03 | 16 | 138 | 2 | C0035828 | |
| Disease | immunoglobulin lambda-like polypeptide 1 measurement | 2.50e-03 | 16 | 138 | 2 | EFO_0801688 | |
| Disease | congenital heart disease | 2.69e-03 | 59 | 138 | 3 | EFO_0005207 | |
| Disease | Inborn Errors of Metabolism | 2.82e-03 | 17 | 138 | 2 | C0025521 | |
| Disease | Benign neoplasm of stomach | 2.82e-03 | 17 | 138 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.82e-03 | 17 | 138 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.82e-03 | 17 | 138 | 2 | C0154060 | |
| Disease | white matter hyperintensity measurement | 3.04e-03 | 302 | 138 | 6 | EFO_0005665 | |
| Disease | lean mass-adjusted fat body mass | 3.16e-03 | 18 | 138 | 2 | EFO_0009890 | |
| Disease | Tinnitus | 3.30e-03 | 130 | 138 | 4 | HP_0000360 | |
| Disease | Ischemic stroke | 4.29e-03 | 324 | 138 | 6 | HP_0002140 | |
| Disease | Stomach Carcinoma | 4.30e-03 | 21 | 138 | 2 | C0699791 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VINDEVKVVTGKDGQ | 441 | Q96L91 | |
| VVVDENDVVKGIVSL | 301 | P54619 | |
| KQVKALEIDVEEQVS | 2021 | Q99996 | |
| GKFAQIIQEKEVEID | 2281 | Q99996 | |
| DIVVKKEDGFTQIVL | 286 | Q9Y6F7 | |
| ELQEVVKVGQASEIA | 306 | Q99459 | |
| VVEKIGEENNKVVEE | 1206 | O94986 | |
| QEQIIQVKELSKGVE | 326 | P41214 | |
| QVKELSKGVESIVAV | 331 | P41214 | |
| IVIGTEQVIEVVKSA | 91 | Q8IVU9 | |
| IQKEVKSVEQQVIGF | 16 | Q9UL15 | |
| QNTGAIENIIVEVKK | 676 | P49711 | |
| EVAVKQIIAGKAVEQ | 636 | Q86V21 | |
| VGETTAKVLKDEIDV | 291 | Q9Y4W6 | |
| KENVVLEVTVLNTEG | 676 | O94910 | |
| SIDSVVIGKDQEVKL | 81 | Q7Z2E3 | |
| VKVPEIKAEQQDVNV | 216 | Q9C0F1 | |
| VFDDVVGIVEIINSK | 381 | Q01518 | |
| VGIVEIINSKDVKVQ | 386 | Q01518 | |
| EEQDFGIEIVKVKAI | 146 | Q96SW2 | |
| THPKVQEVQVVGVKD | 531 | Q96CM8 | |
| EVGAQLVVIKSAEEQ | 286 | Q9NNX6 | |
| KAVEEIVNTGVTVIK | 186 | Q5TEZ5 | |
| KEQTIEIKEEVVGLT | 236 | P11836 | |
| QVKKEVGDVTIVVNN | 106 | Q7Z5P4 | |
| VGATKLEQVKFEICV | 86 | Q7L9B9 | |
| VQEAQVNEEEVKGKI | 281 | Q8NHQ8 | |
| EIIADVKKFLQGTVE | 131 | Q9H2T7 | |
| EVIDEKGNVVLKGEL | 711 | Q15042 | |
| VIGVALQASKKEESV | 621 | Q2KHR3 | |
| KEGASELVIDVIVNT | 1751 | Q14571 | |
| DTKDLTIEKVVINGQ | 56 | P09960 | |
| EVVKVLVKEGANINA | 111 | Q01484 | |
| DAETGKVVIISQDLV | 1146 | Q8TEM1 | |
| EVIQDGVRVFIEKKA | 76 | Q9BUE6 | |
| EEIIVQNGKVIGVKS | 256 | P50395 | |
| EVIAVVEENKVSNGL | 76 | Q9BXT6 | |
| NVVIQVVDKLKGFSI | 661 | Q8NEM0 | |
| IKKGVFVVGAVEQVV | 191 | Q9NS87 | |
| GLEVLKQETAVVENV | 811 | Q14703 | |
| VGKDVVVELKNDLSI | 11 | Q9Y333 | |
| GKVIQEIVDKSGVVR | 311 | P51116 | |
| GKVIQEIVDKSGVVR | 301 | P51114 | |
| VIQEEVVEIDGKQVQ | 131 | Q9NU53 | |
| VVEIDGKQVQQKDVT | 136 | Q9NU53 | |
| GKQVQQKDVTEIDIL | 141 | Q9NU53 | |
| PEIVAKEAQVKVAEV | 441 | O95202 | |
| KEAQVKVAEVEGEQV | 446 | O95202 | |
| QVAEIVATLEKEEKV | 706 | O95202 | |
| HGTIQTEKVDEVIKE | 216 | Q8N1A0 | |
| PEEKVVVQEVVVTQK | 1366 | Q92817 | |
| VVEEIQKQKICGSLT | 326 | Q96M96 | |
| ATIKKDEQTGAIIVA | 151 | Q5T2T1 | |
| IIKQQVEAAETIKEE | 2166 | O94854 | |
| VVIEVKVATQEGKEI | 106 | O75223 | |
| GEEAIVELVENGKKV | 51 | P35579 | |
| QVKEAINVIGVTLKF | 1181 | Q2PPJ7 | |
| KTVVQEVVDGKVVSS | 401 | P35900 | |
| EVVDGKVVSSEVKEV | 406 | P35900 | |
| VIEKKNVKVEVAATE | 601 | P09884 | |
| IVAVVEVVAEGKKRD | 106 | O75161 | |
| KGIAEVKEEIVENGV | 66 | Q99572 | |
| TQGKQVKVVETELQE | 916 | Q8NFC6 | |
| VKVVETELQEGATKQ | 921 | Q8NFC6 | |
| VKIEANVNSVVTEEK | 1636 | Q8NFC6 | |
| EDVAVLKKELVQVQT | 221 | Q15075 | |
| TDVNVVAVELVKKTD | 46 | Q13535 | |
| VVKIEKVLQQGEIGD | 346 | Q8NF50 | |
| DQLIQVVGIEAEKVS | 3081 | Q9UFH2 | |
| EEKVVEAKITEVKIN | 3631 | Q9UFH2 | |
| EVKTLAVDQVNGGKV | 306 | Q53HC0 | |
| DTLGEKQTLVVDVVA | 96 | Q9BPX7 | |
| ETLVKVVIDCKQVGE | 1366 | Q05707 | |
| KVIIVDAENVLVADK | 301 | Q8NDZ4 | |
| QTVAVGVIKNVEKKS | 431 | Q05639 | |
| EALDTGKQTAIIEVV | 591 | Q9NSG2 | |
| VIVLNEGIKVQTKEG | 1231 | O75976 | |
| DVFIEKQKGEILGVV | 656 | Q02410 | |
| VFKSEGCEVILVNVK | 131 | Q8NFQ5 | |
| KVVSDVLKEVEVQEP | 36 | Q9Y586 | |
| VFVTGNAKKLEEVVQ | 11 | Q9BY32 | |
| VEEAIVQSGQKKLVL | 161 | Q9BVP2 | |
| KEVVAEDGTVVTIKQ | 386 | Q8TBB5 | |
| KGAEIKTTNEVVLAV | 401 | Q9HC35 | |
| QGEKAQEGEVEIVVL | 4676 | Q8NDH2 | |
| KETQEGIITIQKELD | 316 | Q9ULB5 | |
| QNGVLVKETAIETKV | 331 | Q9Y4K1 | |
| IVEDAVEQGVLKTQI | 386 | Q7Z3D6 | |
| QEIEVKIVEAVDGKA | 366 | Q8IYK4 | |
| KDVLDIEQFSVVKGI | 476 | P32298 | |
| VIVEKVSGSQIVDID | 31 | P60520 | |
| EVEVKNEIVANVGKR | 301 | Q32MZ4 | |
| SQENIEKEVVGIAHK | 296 | O14832 | |
| EIQEKAVEVATVVIQ | 261 | Q9P2B2 | |
| LKQGEELEVVQKEVA | 301 | Q9GZR2 | |
| FILVVGEKEKIDNAV | 751 | A2RTX5 | |
| KKVNGEIEIRVEQAE | 111 | O14994 | |
| QDGVHIIKETKEEVT | 76 | Q9Y3A2 | |
| VQGEDGQVVLIKQEK | 291 | P05423 | |
| LQETIEQKTKIEIGD | 116 | Q9H668 | |
| EGEKVFEEEIVVQIK | 121 | Q9H1X1 | |
| GQVEIVTKVKDLEKN | 1591 | Q8WUY3 | |
| KVVSDVLKEVEVQEP | 36 | Q13394 | |
| KVNKKEVVEAVTIVE | 66 | P39023 | |
| INEAVEKGIAEQTVV | 221 | Q13576 | |
| EIKSKVDQVQDIVTG | 946 | Q13576 | |
| EEEQKTVALIKAVFG | 106 | Q8NHV1 | |
| TVKQGVDQKLVEGQE | 281 | O60664 | |
| VVKDQLIGQGIIVKD | 46 | Q8NEK8 | |
| VDITKTVIKEGEEQL | 126 | P30876 | |
| VGSFINIEEIKEIVK | 926 | O43166 | |
| VGKKVLVTVEEDDTI | 331 | Q9NR45 | |
| GELDIVVTSNKEVKV | 256 | Q96M27 | |
| GKQVVEKVETERAQL | 351 | Q15562 | |
| ANINKESIVDVEGVV | 106 | P14868 | |
| ESIVDVEGVVRKVNQ | 111 | P14868 | |
| QNKAVLEEGTDVVIK | 431 | Q9NSE4 | |
| VIEVQEVQGKKVARV | 261 | O15160 | |
| GEDEVIAVSEKVIVK | 91 | Q14865 | |
| EIALGTVTNVEEAVK | 901 | Q8N3C0 | |
| SEKIKVGDVVEVQAD | 141 | Q8NB49 | |
| DEVVVELVENGKKVT | 56 | P35749 | |
| TQKTVVKQGLEVKEA | 136 | P24278 | |
| RKAEKQVETEEAGVV | 151 | O75475 | |
| AVDVEQVIGLEKVNK | 506 | Q9Y4G8 | |
| VESGQKKKVVILNVD | 886 | Q14690 | |
| TTEVLCEGIKKVVNV | 396 | Q8N1K5 | |
| VTLVAVEGVKEGIEK | 16 | Q8WWY7 | |
| KVKLVFVEDQAVVET | 196 | Q86XI8 | |
| KGEVVDAVVTQVNKV | 81 | P62487 | |
| IVKKIETENEVKVNG | 171 | Q9UBZ9 | |
| FVNNVAVVKELDGVK | 61 | Q2M3V2 | |
| VLEEAIADGVKVSVK | 471 | Q96N76 | |
| VVDVDVKLGQVSVKN | 31 | O15066 | |
| VQVEQSKVLIKEGGV | 91 | Q16181 | |
| EAGITEKVVFEQTKV | 136 | P60174 | |
| NVVVDTEVTGKKLLE | 551 | O95347 | |
| DKGIKGEEIVQQLIE | 116 | Q9UJA5 | |
| VKGVEEAKQELQEVV | 341 | Q96TA2 | |
| TVNDVVFVIDSGKVK | 696 | Q9H6S0 | |
| EEVKVAGAIGIVKQN | 71 | Q86YA3 | |
| ETQVVLINAIKDVAK | 2076 | Q9Y4G6 | |
| EVADVGIEVKVTKNF | 601 | Q2TB10 | |
| VKIVIKTEVQEEEVV | 281 | Q6NUN9 | |
| AAQEKDGIVIVKVEE | 16 | P17029 | |
| QLVKDGVTQVVVSEE | 2096 | Q9C0G0 | |
| TIENVKAKIQDKEGI | 326 | P0CG48 | |
| ITLKKDQIVVQKGDE | 326 | Q96MF2 | |
| KNVICEESKAVQVIG | 16 | Q5TAX3 | |
| SQKLVKIEEVADVAV | 211 | Q9Y2L8 | |
| VVFVEDVKNVPVGKV | 656 | O95071 | |
| VVVKEELGGDVKVES | 271 | P41229 | |
| VSVETGKDAVVVAKV | 61 | Q14324 |